Xspray Pharma publishes its Year-end Report, January – December 2018

Fourth quarter, October – December 2018, parent company Amounts in brackets refer to the corresponding period for the previous year. • Earnings before tax amounted to SEK -10,597 thousand (-4,964) • Net sales amounted to SEK 206 thousand (20) • Earnings per share before dilution amounted to SEK -0.75 (-0.40) • Cash flow from operating […]